Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Bucher

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|July 9, 1999
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort StudyP P Sendi, H C Bucher, T Harr, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
Swiss Medical Weekly|May 29, 2009
Toxoplasmosis during pregnancy and infancy. A new approach for SwitzerlandK Boubaker, P A Raeber, B Vaudaux, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
HIV Medicine|September 4, 2020
What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohortsA d'Arminio Monforte, F Bonnet, H C Bucher, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
JAMA|April 3, 1996
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trialsH C Bucher, R J Cook, G H Guyatt, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
European Journal of Nuclear Medicine|July 1, 1997
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapyA Otte, E Jermann, M Behe, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|July 9, 1999
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort StudyP P Sendi, H C Bucher, T Harr, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort StudyP P Sendi, B A Craig, G Meier, et al.
Swiss Medical Weekly|May 29, 2009
Toxoplasmosis during pregnancy and infancy. A new approach for SwitzerlandK Boubaker, P A Raeber, B Vaudaux, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Rare AIDS-defining diseases in the Swiss HIV Cohort StudyB Burckhardt, P Sendi, D Pfluger, et al.
HIV Medicine|September 4, 2020
What do the changing patterns of comorbidity burden in people living with HIV mean for long-term management? Perspectives from European HIV cohortsA d'Arminio Monforte, F Bonnet, H C Bucher, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
JAMA|April 3, 1996
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trialsH C Bucher, R J Cook, G H Guyatt, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
European Journal of Nuclear Medicine|July 1, 1997
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapyA Otte, E Jermann, M Behe, et al.
Pageof 9